Zhicong Zhao, M.D., Ph.D.

626-218-5628
Zhicong Zhao, M.D., Ph.D.
Visiting Scholar, Department of Systems Biology
Research Area
  • Role of M6A Modification in NAFLD-NASH-HCC Axis
  • Therapeutic Value of M6A Inhibitors in Antitumor Immunity
Research Teams
Systems Biology
Zhicong Zhao, Ph.D., is a visiting scholar in the Jianjun Chen Lab in the Department of Systems Biology at City of Hope.

Location

Education & Experience

Degrees

  • 2017-present, Ph.D. candidate, Surgery, Shanghai Jiao Tong University, Shanghai, China

  • 2012-2017, B.S. and M.D., Clinical Medicine, Shanghai Jiao Tong University, Shanghai, China

Professional Experience

  • 2020-present, Visiting Scholar, Department of Systems Biology, Beckman Research Institute of City of Hope, Duarte, California

Awards & Memberships

Awards

  • 2017, Zhiyuan Honors Program for Graduate Students of Shanghai Jiao Tong University

  • 2017, Outstanding Graduate Student of Shanghai Jiao Tong University

Memberships

  • American College of Surgeons

Publications

Zhao Z, Meng J, Su R, Zhang J, Chen J, Ma X, Xia Q. Epitranscriptomics in liver disease: Basic concepts and therapeutic potential. Journal of Hepatology. 2020; DOI:10.1016/j.jhep.2020.04.009.

Wang J, Hu B, Zhao Z, Zhang H, Zhang H, Zhao Z, Ma X, Shen B, Sun B, Huang X, Hou J, Xia Q. Intracellular XBP1-IL-24 axis dismantles cytotoxic unfolded protein response in the liver. Cell Death Dis. 2019, 11(1), 17.

Hou J, Zhang H, Liu J, Zhao Z, Wang J, Lu Z, Hu B, Zhou J, Zhao Z, Feng M, Zhang H, Shen B, Huang X, Sun B, He C, Xia Q. YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma. Molecular Cancer. 2019, 18(1), 163.